Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

Future changes to treatment strategies are likely to involve the earlier use of biological treatments ... Questionnaire Disability Index; RA: Rheumatoid arthritis; SF-36: Short Form-36; TSGS ...

Treatments for arthritis include medications ... National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS ...

The Waterloo Road actor appeared on This Morning and revealed he is turning to lifestyle changes to help manage his condition ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

The second type is rheumatoid arthritis ... board-certified and trained to diagnose and focus on non-surgical treatments of arthritis and related diseases. Dr. Kelsey Pasch of The Baton Rouge ...

An X-ray will show the extent of arthritis. The X-ray may also offer some indication of how successful nonoperative treatments may be in your situation. Most people who have arthritis in the thumb ...

Objective This study examined the safety and efficacy of biological agents, especially tumour necrosis factor (TNF) inhibitors, for HIV-positive rheumatology patients refractory to standard therapy.

Objectives A reduced adrenal reserve-associated cortisol production relative to the enhanced needs of chronic inflammation (disproportion principle) has been observed in rheumatoid arthritis (RA). We ...